CME Group Inc. (CME)

CME Income Statement

Revenue, expenses, and profitability analysis

CME Quarterly Income Statement (USD)

Quarterly Report	TTM	03/31/2026	12/31/2025	09/30/2025	06/30/2025	03/31/2025	12/31/2024	09/30/2024	06/30/2024
Gross Profit	5.835B	1.657B	1.408B	1.300B	1.470B	1.436B	1.304B	1.366B	1.328B
Revenue	6.758B	1.880B	1.649B	1.538B	1.692B	1.642B	1.525B	1.584B	1.532B
Cost of Goods Sold	923.300M	223.000M	241.100M	237.600M	221.600M	206.700M	220.800M	218.800M	204.700M
Gross Profit Margin	88.1%	88.1%	85.4%	84.5%	86.9%	87.4%	85.5%	86.2%	86.6%
Total Operating Expenses	1.404B	347.400M	388.000M	327.400M	341.100M	327.600M	357.400M	341.400M	327.200M
Research & Development	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Selling, General & Administrative	150.200M	28.200M	47.900M	36.700M	37.400M	28.500M	33.900M	31.000M	34.700M
Operating Income (EBIT)	4.431B	1.310B	1.020B	972.600M	1.129B	1.108B	947.100M	1.024B	1.001B
Operating Margin	69.7%	69.7%	61.8%	63.3%	66.7%	67.5%	62.1%	64.6%	65.3%
Income Before Tax (EBT)	5.597B	1.511B	1.578B	1.177B	1.330B	1.245B	1.097B	1.177B	1.155B
Interest Income	1.777B	—	1.777B	—	—	—	—	—	—
Interest Expense	131.600M	43.600M	—	44.000M	44.000M	41.700M	40.700M	40.200M	40.100M
Other Income/Expense	1.165B	201.200M	558.800M	204.400M	201.000M	136.800M	149.500M	152.700M	153.900M
Net Income	4.242B	1.154B	1.168B	908.000M	1.012B	956.200M	874.600M	912.800M	883.200M
Income Tax Expense	1.341B	356.600M	410.400M	269.000M	305.200M	288.600M	222.000M	264.100M	271.300M
Net Profit Margin	61.4%	61.4%	70.8%	59.1%	59.8%	58.2%	57.3%	57.6%	57.6%
EBITDA	5.688B	1.337B	1.590B	1.304B	1.458B	1.369B	1.221B	1.301B	1.279B
EBITDA Margin	71.1%	71.1%	96.4%	84.8%	86.2%	83.4%	80.0%	82.1%	83.4%
Depreciation & Amortization	219.700M	27.200M	26.500M	82.600M	83.400M	82.500M	83.400M	83.900M	84.200M
EPS Basic	11.80	3.25	3.25	2.49	2.81	2.63	2.40	2.51	2.43
EPS Diluted	11.72	3.18	3.24	2.49	2.81	2.62	2.40	2.50	2.42
Shares Outstanding	359.318M	359.318M	359.633M	359.653M	359.636M	359.613M	359.389M	359.400M	359.330M
Diluted Shares Outstanding	363.208M	363.208M	360.233M	360.330M	360.297M	360.227M	360.050M	359.989M	359.869M

CME Annual Income Statement (USD)

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Gross Profit	5.614B	5.280B	4.750B	4.266B	3.853B	4.027B	3.969B	3.637B
Revenue	6.521B	6.130B	5.579B	5.019B	4.690B	4.884B	4.868B	4.309B
Cost of Goods Sold	907.000M	850.300M	828.600M	753.100M	837.000M	856.500M	898.700M	672.200M
Gross Profit Margin	86.1%	86.1%	85.1%	85.0%	82.2%	82.5%	81.5%	84.4%
Total Operating Expenses	1.384B	1.348B	1.315B	1.250B	1.208B	1.390B	1.381B	1.030B
Research & Development	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Selling, General & Administrative	150.500M	132.700M	144.400M	137.400M	151.700M	191.300M	174.100M	166.100M
Operating Income (EBIT)	4.229B	3.932B	3.436B	3.016B	2.645B	2.637B	2.588B	2.608B
Operating Margin	64.9%	64.1%	61.6%	60.1%	56.4%	54.0%	53.2%	60.5%
Income Before Tax (EBT)	5.330B	4.541B	4.154B	3.490B	3.374B	2.722B	2.690B	2.778B
Interest Income	—	—	—	—	—	—	—	—
Interest Expense	129.700M	160.900M	159.400M	162.700M	166.900M	166.200M	178.000M	157.700M
Other Income/Expense	1.101B	609.900M	717.900M	474.400M	728.400M	84.700M	101.800M	170.200M
Net Income	4.044B	3.526B	3.226B	2.691B	2.636B	2.105B	2.116B	1.962B
Income Tax Expense	1.273B	1.016B	927.400M	799.300M	736.700M	615.700M	573.800M	814.100M
Net Profit Margin	62.0%	57.5%	57.8%	53.6%	56.2%	43.1%	43.5%	45.5%
EBITDA	5.720B	5.039B	4.666B	4.016B	3.926B	3.353B	3.341B	3.184B
EBITDA Margin	87.7%	82.2%	83.6%	80.0%	83.7%	68.7%	68.6%	73.9%
Depreciation & Amortization	275.000M	336.800M	352.600M	362.600M	385.400M	464.400M	2.280B	1.764B
EPS Basic	11.18	9.69	8.87	7.41	7.30	5.88	5.93	5.73
EPS Diluted	11.16	9.67	8.86	7.40	7.29	5.87	5.91	5.71
Shares Outstanding	359.633M	359.389M	359.023M	358.713M	358.340M	357.764M	357.155M	342.344M
Diluted Shares Outstanding	360.233M	359.944M	359.500M	359.181M	358.929M	358.524M	358.239M	343.737M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About CME Group Inc.

CME Group Inc., through its various subsidiaries, manages international marketplaces for the exchange of futures and options on futures contracts worldwide. Its extensive array of product offerings includes futures and options linked to a broad spectrum of underlying assets, such as interest rates, equity indices, foreign exchange, agricultural commodities, energy, and metals, alongside fixed-income products. The company additionally furnishes essential clearinghouse services, which entail the verification, settlement, and guarantee of futures, options, and cleared swap agreements traded across its venues. It also offers services for transaction processing and risk mitigation. Furthermore, the organization provides diverse market data services, encompassing both real-time and historical data feeds. Its wide-ranging client base consists of professional traders, financial institutions, both institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. Founded in Chicago, Illinois, in 1898, the enterprise was formerly known as Chicago Mercantile Exchange Holdings Inc. before rebranding as CME Group Inc. in July 2007.

Chicago, IL

3,760 employees

www.cmegroup.com

Financial Services / Financial - Data & Stock Exchanges

Sector: Financial Services
Industry: Financial - Data & Stock Exchanges
CEO: Terrence A. Duffy

View full financials